Support
von Herrath
Neuro-immune crosstalk in the pancreas during onset of type 1 diabetes

Team: Gustaf Christoffersson The histopathologic features of human type 1 diabetes are remarkably heterogeneous throughout the pancreas. One lobule of

READ MORE
von Herrath
Modeling and detection of viral infections in human pancreas slices

Team: Mehdi Benkahla It is thought that an interaction between predisposing genes and environmental factors, such as viral infections, may

READ MORE
von Herrath
Characterization of HLA class I expression in autoantibody positive and type 1 diabetic donors

Team: Mehdi Benkahla and Somayeh Sabouri Type 1 diabetes (T1D) is an autoimmune disease characterized by increased blood glucose levels

READ MORE
von Herrath
Detailed in-situ characterization of cytokines, immune and endocrine cell in the human pancreas

Team: Sakthi Rajendran, Estefania Quesada-Masachs, Christine Bender Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of

READ MORE
von Herrath
Characterization of in-situ IL17 expression in human pancreas

Team: Sakthi Rajendran, Estefania Quesada-Masachs and Mehdi Benkahla IL-17 is a pro-inflammatory cytokine important in shaping host immune responses against

READ MORE
von Herrath
Expression of HLA class II in human pancreatic tissue sections

Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing β cells are attacked

READ MORE
von Herrath
Exploring toxic effects of T1D patient’s serum in pancreatic β cells

Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D), an autoimmune disease that usually affects young people, is on the

READ MORE
von Herrath
Characterization of specificity and phenotype of pancreatic CD8 T cells in human Type 1 Diabetes

Team: Christine Bender A better understanding of type 1 diabetes (T1D) is the first step to potentially developing new therapies

READ MORE
von Herrath Lab
Matthias Von Herrath, M.D.
Professor
Center for Autoimmunity and Inflammation

Matthias von Herrath, M.D., is committed to clinical translation of immune-based interventions in autoimmune and metabolic diseases, the latter in particular being an exciting emerging field.

Read More
Load More